00:28 , Jul 25, 2019 |  BC Extra  |  Financial News

July 24 Financial Quick Takes: $500M for Seattle Genetics; plus X-Vax, TScan, Alexion and more

Seattle Genetics raises $500M follow-on  Seattle Genetics Inc. (NASDAQ:SGEN) raised $500 million late Tuesday through the sale of 7.1 million shares at $70. The price is an 8% discount to the company's close of $75.95...
22:27 , Jul 22, 2019 |  BC Extra  |  Financial News

July 22 Financial Quick Takes: Shanghai's rising STAR; plus Retrotrope and RAPT

Broad gains in debut of Shanghai's STAR market  The first group of 25 companies soared out of the gate on the Shanghai exchange’s science and technology innovation board, posting average gains of 140% in their...
23:56 , Jul 8, 2019 |  BC Extra  |  Financial News

On heels of series C extension, RAPT Therapeutics files for IPO

Just weeks after topping off its series C round, Flexus spinout RAPT Therapeutics Inc. (South San Francisco, Calif.) has filed to raise up to $86.3 million in an IPO on NASDAQ underwritten by BofA Merrill...
00:09 , Jun 27, 2019 |  BC Extra  |  Financial News

June 26 Financial Quick Takes: Adaptive prices upsized IPO; plus BridgeBio, Medicines Co., Global Blood, Odonate

Adaptive raises $300M in IPO  Adaptive Biotechnologies Inc. (NASDAQ:ADPT) raised $300 million through the sale of 15 million shares at $20 in an IPO on NASDAQ. The deal price values the computation immunology and diagnostics...
22:58 , Jun 18, 2019 |  BC Extra  |  Financial News

June 18 Financial Quick Takes: Biohaven sinks on fund-raising news; plus IPO trio sets terms

Amid buyout rumors, Biohaven proposes follow-on  Biohaven Pharmaceutical Holding Co. Ltd. (NYSE:BHVN) lost $13.54 (24%) to $43.83 on Tuesday, shedding more than half a billion dollars in market cap, after it proposed to raise $300...
20:36 , May 31, 2019 |  BC Extra  |  Financial News

New IPO filings include Adaptive, Morphic

Immunosequencing company Adaptive and integrin company Morphic each filed for IPOs on NASDAQ Thursday, while antipsychotic therapy developer Karuna revealed details of its planned listing on the exchange on Friday. Adaptive Biotechnologies Corp. (Seattle, Wash.)...
00:29 , May 25, 2019 |  BC Extra  |  Financial News

New IPO filings include BridgeBio, Dermavant, Prevail, Atreca, Akero

In a week in which two biotechs went public and a third opted for a billion-dollar takeout instead of an IPO, five companies filed on Friday to list on NASDAQ in IPOs that could raise...
18:46 , Feb 15, 2019 |  BC Week In Review  |  Financial News

TCR2 raises $75M in IPO

TCR2 Therapeutics Inc. (NASDAQ:TCRR) raised $75 million in an IPO priced Feb. 13. The immuno-oncology company priced 5 million shares at $15, the midpoint of its proposed range of $14-$16. The price valued TCR2 at...
05:01 , Feb 15, 2019 |  BC Extra  |  Financial News

Stealth Bio prices $78M IPO at bottom end of range

Stealth BioTherapeutics Corp. (NASDAQ:MITO) closed down $0.10 to $11.90 Friday after raising $78 million in its IPO. Late Thursday, the company priced more ADSs than anticipated at the bottom end of its proposed range. The...
05:02 , Feb 14, 2019 |  BC Extra  |  Financial News

TCR2 prices $75M IPO at midpoint

TCR2 Therapeutics Inc. (NASDAQ:TCRR) raised $75 million in an IPO priced late Wednesday. The company added $0.07 to $15.07 in its first day of trading Thursday. The immuno-oncology company priced 5 million shares at $15,...